ReviewFrontiers in pharmacology2024

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

Diana V Ávila-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.